<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>CARDIAC AND RENAL PROTECTIVE EFFECTS OF Andrographis paniculata LEAF EXTRACT IN MALE WISTAR RATS</title>
<link href="http://hdl.handle.net/123456789/341" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/123456789/341</id>
<updated>2026-04-08T22:54:11Z</updated>
<dc:date>2026-04-08T22:54:11Z</dc:date>
<entry>
<title>CARDIAC AND RENAL PROTECTIVE EFFECTS OF Andrographis paniculata LEAF EXTRACT IN MALE WISTAR RATS</title>
<link href="http://hdl.handle.net/123456789/342" rel="alternate"/>
<author>
<name>ADEOYE, BISI OLAJUMOKE</name>
</author>
<id>http://hdl.handle.net/123456789/342</id>
<updated>2019-04-02T10:41:30Z</updated>
<published>2018-04-01T00:00:00Z</published>
<summary type="text">CARDIAC AND RENAL PROTECTIVE EFFECTS OF Andrographis paniculata LEAF EXTRACT IN MALE WISTAR RATS
ADEOYE, BISI OLAJUMOKE
Cardiovascular and renal diseases are one of the leading causes of morbidity and&#13;
mortality in humans. However, conventional drugs used for treatment of these diseases&#13;
have adverse effects and are not readily affordable. Botanicals such as Andrographis&#13;
paniculata rich in antioxidants are promising alternatives. Hence, protective effect of&#13;
Ethanol Leaf Extract of Andrographis paniculata (EEAP) in isoproterenol-induced&#13;
myocardial infarction and cisplatin-induced renal injury in rats were investigated.&#13;
Fresh leaves of Andrographis paniculata (Voucher No:UIH-2846) was extracted using&#13;
ethanol. Cardioprotective effects of EEAP were evaluated in male wistar rats (n=49;&#13;
100-160 g) equally divided into seven groups. Group A (control) was administered&#13;
normal saline, group B; isoproterenol at 85 mg/kg, groups C, D, E and F were&#13;
pretreated with enalapril 10 mg/kg, EEAP 100, 200 or 400 mg/kg, respectively, for 7&#13;
days and thereafter administered isoproterenol on days 8 and 9. Group G was&#13;
administered isoproterenol on days 1 and 2, thereafter treated with 200 mg/kg of EEAP&#13;
for 7 days. Administration of isoproterenol was subcutaneous, while enalapril and&#13;
EEAP were oral. Electrocardiogram and blood pressure (BP) parameters were done on&#13;
day 10 and animals were sacrificed 24 hours later. Cardiac tissues were assayed for&#13;
markers of oxidative stress (malondialdehyde, H2O2), and antioxidant defence system&#13;
(SOD, GPx, GST). Histopathology and immunohistochemistry (Cardiac troponin-I, Creactive&#13;
protein, Interleukin-10) were evaluated. Renoprotective effects of EEAP were&#13;
evaluated in another 49 wistar rats (100-150 g) divided into seven equal groups. Group&#13;
A1 (control), group B1 was treated with cisplatin (10 mg/kg) only on day 8, groups&#13;
C1 and D1 were pre-treated with EEAP (200 and 400 mg/kg, respectively), for seven&#13;
days and cisplatin was administered on day 8. Group E1 received cisplatin only on day&#13;
1, groups F1 and G1 received cisplatin on day 1; 72 hours after EEAP (200 and 400&#13;
mg/kg) were administered, respectively, for 7 days. Administration of cisplatin was&#13;
intraperitoneal, while EEAP was oral. Nephroprotective effects were evaluated using&#13;
markers of oxidative stress (protein carbonyl, H2O2), histopathology and&#13;
immunohistochemistry [Kidney injury molecule-1, Nuclear factor (erythroid-derived&#13;
2)-like 2]. Data were analysed using descriptive statistics and ANOVA at α0.05.&#13;
Reduced BP caused by isoproterenol was restored to near normal values in group F&#13;
(systolic BP 102.33±2.31 to 131.50±2.1 mmHg, diastolic BP 82.67±1.80 to&#13;
iii&#13;
101.70±1.3 mmHg). Treatment in group G restored prolonged QT interval&#13;
(140.21±4.10 to 75.55±3.01 ms), significantly reduced Malondialdehyde (5.98±0.44 to&#13;
4.24±0.39 μmol/mgprotein) and H2O2 (13.73±1.30 to 11.44±0.49 μmol/mgprotein), but&#13;
increased SOD (1.74±0.05 to 1.98±0.14 U/mgprotein), and GST (19.99±0.68 to&#13;
23.99±1.38 units/mg tissue). Groups E and F had reduced cellular infiltration,&#13;
downregulated CTnI and CRP, but upregulated IL-10 expressions. Treatment in group&#13;
D1 significantly decreased protein carbonyl (40.12±5.93 to 23.85±6.45&#13;
nmoles/mgprotein), H2O2 (29.93±0.87 to 26.65±0.74 μmol/mgprotein), increased&#13;
activities of SOD (48.28±1.24 to 52.94±2.17 U/mgprotein), GPx (52.95±2.00 to&#13;
55.92±1.92 mmole/GSH complex formed/min/mg protein) and downregulated Kim-1&#13;
but upregulated Nrf2 expressions.&#13;
Andrographis paniculata at 200 mg/kg exhibited cardiac and renal protective activities&#13;
through its antioxidant and anti-inflammatory properties. Therefore, it is a potential&#13;
candidate in treatment of cardiovascular and renal diseases.&#13;
Keywords: Andrographis paniculata, Phyto-antioxidant, Myocardial infarction, Renal injury&#13;
Word count: 497
</summary>
<dc:date>2018-04-01T00:00:00Z</dc:date>
</entry>
</feed>
